Making Sense of Drug Pricing Legislation
U.S. House Democrats Introduce Sweeping Medicare for All Bill
Year in Review: The Impact of Advocacy & RheumPAC in 2018
The ACR’s 2018 Legislative & Regulatory Priorities
Protect Your Patients’ Access to Care & Treatment
Year in Review: The ACR/ARHP/RheumPAC’s Advocacy Efforts in 2017
Doctors & Political Advocacy: Tips to Get You Started
The American College of Rheumatology’s Legislative Successes of 2017
The ACR Lobbies Against New Part B Drug Cost Adjustment Rule
- 1
- 2
- 3
- …
- 19
- Next Page »